Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
1.14
0.06 (5.56%)
At close: Aug 14, 2025, 3:59 PM
1.14
0.44%
After-hours: Aug 14, 2025, 06:43 PM EDT

Cytosorbents Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
35.59M 31.08M 29.36M 40.11M
Cost of Revenue
10.47M 9.13M 13.96M 11.05M
Gross Profit
25.13M 21.95M 15.4M 29.06M
Operating Income
-16.79M -31.95M -31.52M -22.75M
Interest Income
n/a n/a 133K 28K
Pretax Income
-22.41M -30.06M -33.91M -25.3M
Net Income
-20.72M -29.25M -32.81M -24.56M
Selling & General & Admin
35M 38.31M 37.14M 38.48M
Research & Development
6.92M 15.59M 15.12M 16.38M
Other Expenses
n/a n/a -5.33M -3.06M
Operating Expenses
41.91M 53.9M 46.93M 51.81M
Interest Expense
1.4M 157.89K n/a n/a
Selling & Marketing Expenses
n/a 435.05K n/a n/a
Cost & Expenses
52.38M 63.03M 60.88M 62.85M
Income Tax Expense
-1.69M -813.74K -1.09M -736K
Shares Outstanding (Basic)
54.43M 44.66M 43.57M 43.36M
Shares Outstanding (Diluted)
54.43M 44.66M 43.57M 43.36M
EPS (Basic)
-0.38 -0.65 -0.75 -0.57
EPS (Diluted)
-0.38 -0.65 -0.75 -0.57
EBITDA
-19.26M -27.88M -32.77M -21.62M
EBIT
-21.01M -29.9M -33.91M -22.74M
Depreciation & Amortization
1.74M 2.02M 1.13M 1.13M